Effect of food on the pharmacokinetics and safety profiles of a new PARP inhibitor fuzuloparib capsules in healthy volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of food on the pharmacokinetics and safety profiles of a new PARP inhibitor fuzuloparib capsules in healthy volunteers

Published:2024-05-04 Issue:2 Volume:94 Page:251-257
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Du Pengfei,Long Yao,Wang Minhui,Huang Yunzhe,Wang Yaqin,Chen Xinyan,Lin Yuhong,Wu Jianbang,Shen Jie,Jia Yuanwei

Funder

Special Foundation for Talents of Yijishan Hospital

"Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College

“Climbing Peak” Training Program for Innovation Technology team of Yijishan Hospital, Wannan Medical College

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00280-024-04672-6.pdf

Reference36 articles.

1. Kamel D, Gray C, Walia JS, Kumar V (2018) PARP inhibitor drugs in the treatment of breast, ovarian, prostate and pancreatic cancers: an update of clinical trials. Curr Drug Target. https://doi.org/10.2174/1389450118666170711151518

2. Dziadkowiec KN, Gąsiorowska E, Nowak-Markwitz E, Jankowska A (2016) PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting. Menopausal Rev 4:215–219. https://doi.org/10.5114/pm.2016.65667

3. Thomas C, Tulin AV (2013) Poly-ADP-ribose polymerase: machinery for nuclear processes. Mol Aspects Med 34(6):1124–1137. https://doi.org/10.1016/j.mam.2013.04.001

4. D’Andrea AD (2018) Mechanisms of PARP inhibitor sensitivity and resistance. DNA Repair 71:172–176. https://doi.org/10.1016/j.dnarep.2018.08.021

5. Cortesi L, Rugo HS, Jackisch C (2021) An overview of PARP inhibitors for the treatment of breast cancer. Target Oncol 16(3):255–282. https://doi.org/10.1007/s11523-021-00796-4

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIL‐IS LC–ESI–MS/MS method for simultaneous quick detection of amoxicillin and clavulanic acid in human plasma: Development, validation and its application to a pharmacokinetics study;Biomedical Chromatography;2024-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3